Board of Directors

Exceptional expertise

The board of directors offers exceptional expertise in aging research, global business development, and entrepreneurship – critical pillars in crafting a robust roadmap for LongeViance.

Their strengths are further enhanced by the deep insights of experienced advisors, complementing the profound expertise of Thomas Lenz, Prof. Trevor Archer and Roger Karlsson.

Prof. Trevor Archer

Professor Emeritus - Research leader
Professor of Biological Psychology. World-top neuro-inflammation scientist (433 papers, 10 k+ citations); has steered AgeViva-Milmed research since 2007 and chairs our Scientific Advisory Board

Roger Karlsson

Chairman of the board
Veteran deal-maker behind multiple exits.

Thomas Lenz

CEO
Experienced entrepreneur; business development

Johan Olsson

Board Member
Johan Olsson has 25+ years in life sciences and valuation, corporate development, investments with success in fundraising and partnerships
Targeting the Biology of Ageing

AgeViva supports mitochondrial function, reduces oxidative stress, and promotes healthy immune regulation. Together, these actions aim to preserve homeostasis—the body’s capacity to keep internal systems in balance despite ageing and external stress.
Longevience AB
Org.nr:559500-0778
info@longevience.com